Article
KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.
Cancer letters - 28 Jan 2020
Forgione Michelle O, McClure Barbara J, Eadie Laura N, Yeung David T, White Deborah L
Abstract excerpt
KMT2A rearranged (KMT2Ar) acute lymphoblastic leukaemia (ALL) is a high-risk genomic subtype, with long-term survival rates of less than 60% across all age groups. These cases present a complex clinical challenge, with a high incidence in infants, high-risk clinical features and propensity for aggressive relapse. KMT2A rearrangements are highly pathogenic leukaemic drivers, reflected by the high incidence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
